Enliven Therapeutics, Inc.ELVNNASDAQ
Loading
Profit from core business operations before interest and taxes
Latest
$-119.66M
↓ 154% vs avg
Percentile
P0
Near historical low
Streak
5 yr
Consecutive declineContracting
Average
$-47.15M
Historical baseline
| Period | Value | YoY Change |
|---|---|---|
| TTM | $-119.66M | -14.4% |
| 2024 | $-104.55M | -25.2% |
| 2023 | $-83.53M | -115.3% |
| 2022 | $-38.79M | -56.7% |
| 2021 | $-24.76M | -165.7% |
| 2020 | $-9.32M | +61.4% |
| 2019 | $-24.12M | -125.9% |
| 2018 | $-10.68M | -19.9% |
| 2017 | $-8.90M | - |